Webcast Year-End Report 2018

The Year-end Report for 2018 and an operational update was presented by CEO Jakob Lindberg and members of Oncopeptides management team, February 22, 2019 at 14:00 (CET). The conference was streamed via...

ASH 2018 – presentations and articles

During the American Hematology Meeting (ASH), Oncopeptides presented data from two ongoing studies, ANCHOR and HORIZON. These presentations as well as publications in the media are presented below. The...

ASH Abstracs 2018

Oncopeptides to present updated data from the two ongoing trials ANCHOR and HORIZON in patients with RRMM at ASH in December 2018. The abstract data cut for ANCHOR was July 18th and for HORIZON, May 10th....

ASH summary Webcast

Oncopeptides had a press conference on December 13. The conference was recorded. Click here to view the Webcast.
Back to top